Su Liu

No ORCID on file · 6 papers in corpus
observational 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1784682

INTRODUCTION: PCOS is the most common disorder encompassing reproductive, metabolic, and endocrine abnormalities, and has an increased risk of adverse pregnancy and neonatal complications, such as miscarriage, gestational diabetes mellitus,…

observational 2025
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01453-5

BACKGROUND: This retrospective cohort study aimed to evaluate the impact of insulin resistance (IR) on clinical outcomes in polycystic ovary syndrome (PCOS) patients undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injectio…

observational 2022
BMC pregnancy and childbirth ·doi:10.1186/s12884-022-04518-0

OBJECTIVE: The current study was undertaken to investigate the relationship between antimüllerian hormone (AMH) and polycystic ovarian syndrome (PCOS) phenotypes and to determine whether AMH is associated with pregnancy outcomes in infertil…

other 2022
Frontiers in genetics ·doi:10.3389/fgene.2022.874487

The aim of this work was to identify the transcriptomic characteristics of the endometrium in normoweight and overweight/obese polycystic ovary syndrome (PCOS) potentially underlying the pathogenesis. This study included 38 patients undergo…

observational 2021
BMC pregnancy and childbirth ·doi:10.1186/s12884-020-03511-9

BACKGROUND: Indoleamine 2,3-dioxygenase (IDO) has been reported to play a key role in placental development during normal pregnancy. However, the question of whether endometrial IDO expression affects in vitro fertilization (IVF) pregnancy …

other 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.575337

BACKGROUND: The risk of adverse pregnancy outcomes is increased by having a polycystic ovary syndrome (PCOS) diagnosis. However, the confounders in previous studies preclude firm conclusions, and further studies are warranted. OBJECTIVES: …